Jinnah Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
NCT Number: NCT06292442
To determine the effects of High-Intensity Interval Training on muscle strength, atrophy, and aerobic capacity in stroke patients.
Looking for future studies?
Notify Me40 year–60 year
All sexes
Interventional
Not applicable
Lahore, Punjab Province, 54000, Pakistan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group received conventional physical therapy treatment including Range of Motion (ROM) exercises for the affected hip, knee, and ankle joints, as well as stretching exercises for tight lower limb muscles, administered 3 times per week for 4 weeks, with each session lasting approximately 20-30 minutes.
This group received High Intensity interval training along with conventional treatment for lower limb muscles, performed 3 times per week fr 4 weeks.
Time frame: 4th week
Manual Muscle Testing is a test that is used to assess muscle strength.
Time frame: 4th week
Measuring tape is used to measure the calf circumference to measure the atrophy, muscle size over time.
Time frame: 4th week
6-Minute Walk Test (6MWT) used to measure Functional capacity, aerobic fitness and endurance.
Time frame: 4th week
Harvard Step Test is used to measure Functional capacity, aerobic fitness and endurance.
Time frame: 4th week
10-Meter Walk Test is a test used for assessing gait speed, monitoring rehabilitation progress, functional assessment, fall risk assessment, and research purposes.
Riphah International University
Other
Effects of High-Intensity Interval Training on Muscle Strength, Atrophy and Aerobic Capacity in Stroke Patients.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06910254
Atrophy, Brain Diseases
Seoul, South Korea
View Trial DetailsNCT02052024
Atrophy, Brain Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details